tm4sf1 car-t
Cell therapyexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 30, 2023 (NCT05673434)
Timeline
No events for the selected filters.
Mechanism of action
- Transmembrane 4 L6 family member 1Immunity, passive
immunity, passive - tm4sf1
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05673434 | N/A | Jan 30, 2023 | Changhai Hospital, Immune Therapeutics |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Changhai Hospital | Academic/Hospital | 1 | 1 | 1 | 2023 |
| Immune Therapeutics | For profit | 1 | 0 | 1 | 2023 |
2 organizations
Page 1 / 1